Sanovas launches next-gen imaging; Reps urge device tax action;

 @FierceMedDev: Medtronic teams up with ARCA for a-fib trial. More | Follow @FierceMedDev

 @MarkHFierce: Device and Dx companies are seeing a softening in demand, even with the health reform law still ramping up. Article | Follow @MarkHFierce

 @DamianFierce: As it prepares to go public, Quintiles pulled in $927M in revenue last quarter, 4.2% growth. More | Follow @DamianFierce

> Sanovas is rolling out what it bills as next-generation imaging technology to help add imaging capacity to existing endoscopic or other surgical instruments. Release

> ERBA Diagnostics ($ERB) disclosed the NYSE has determined it is not in compliance with listing requirements because it did not file an annual report with the SEC for fiscal 2012. Release

> Sanomedics, a maker of sleep disorder treatment devices, will buy Prime Time Medical for $3 million. Both are based in Florida. Item

> TriReme won Japanese approval for its Glider PTCA catheter, signing a deal with local outfit Century Medical to distribute the device. News

> Watermark Medical, developer of a device to help treat sleep apnea, has raised $32.2 million since March, according to an SEC filing. Story

> Reps. Erik Paulsen (R-MN) and Ron Kind (D-WI) are urging congressional action on the medical device tax repeal effort. Letter

Biotech News

 @FierceBiotech: AstraZeneca works both sides of the Atlantic in forging new cancer drug deals. More | Follow @FierceBiotech

 @JohnCFierce: India's clinical trial industry shrivels in wake of safety controversy. Report | Follow @JohnCFierce

 @RyanMFierce: Eli Lilly targets journos on Twitter and Facebook as pharma coverage goes social. Story | Follow @RyanMFierce

> Bristol-Myers rebounds on hep C front with new Merck partnership. News

> AstraZeneca and Boston biotech unite to blast cancer with a nanotech drug. Story

Pharma News

 @FiercePharma: To expand HPV vaccination, U.S. public health types should take hints from their Aussie counterparts. Report | Follow @FiercePharma

 @EricPFierce: Alcohol dependence drug Selincro may provide some relief for Lunbeck's Lexapro hangover. News | Follow @EricPFierce

> Aussie stats show HPV shots effective, but will U.S. parents listen? Story

> Top AstraZeneca investor backs Soriot and his 'golden hello.' More

> Ready to target GlaxoSmithKline, Sanofi wins 6-in-1 vaccine nod in EU. Article

CRO News

> Quintiles' revenue jumps 4.2% in Q1. News

> Indian clinical trials plunge amid increased scrutiny. Article

> Ex-Aptuit researcher jailed over falsified trial results. Story

> Covance bets on Singapore with central lab expansion. More

> GSK, Allergan marred by CMO setbacks. News

Biotech IT News

> Eli Lilly targets journos on Twitter and Facebook as pharma coverage goes social. More

> Multiple myeloma data project could drive innovation. Article

> TEDMED lifts ViS above eClinical throng. Story

> Top 10 Biotech IT Investments in the past year. Special report

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.